David Scholfield

Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer

Matthew Simms, David Scholfield, Elizabeth R. Jacobs et al. · British Journal of Cancer · 2000 · 75 citations · Full text

Medicine, Endocrinology, Oncology +16

Evaluation of Cognitive Function in Healthy Older Subjects Treated with Fesoterodine

Gary G. Kay, Paul Maruff, David Scholfield et al. · Postgraduate Medicine · 2012 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +14

Demographic diversity of participants in Pfizer sponsored clinical trials in the United States

Melinda M. Rottas, Peter F. Thadeio, Rachel N. Simons et al. · Contemporary Clinical Trials · 2021 · 51 citations · Full text

Medicine, Demography, Pharmacology +13

Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer.

Andrea Murray, Matthew Simms, David Scholfield et al. · PubMed · 2001 · 42 citations

Medicine, Nuclear Medicine, Oncology +17

Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double‐blind, placebo‐controlled <scp>EIGHT</scp> trial

Christopher R. Chapple, Tim Schneider, François Haab et al. · British Journal of Urology · 2014 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +17